Cargando…
Efficacy and Tolerability of STOPAIN for a Migraine Attack
Objective: To determine whether topical menthol 6% gel will relieve a migraine attack. Materials and Methods: A single-center, open-label pilot trial of 25 patients with at least 1 year of diagnosed episodic migraine and <15 headache days per month. Patients treated one migraine attack with STOPA...
Autores principales: | St. Cyr, Andrea, Chen, Ashley, Bradley, Kathleen C., Yuan, Hsiangkuo, Silberstein, Stephen D., Young, William B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316718/ https://www.ncbi.nlm.nih.gov/pubmed/25699012 http://dx.doi.org/10.3389/fneur.2015.00011 |
Ejemplares similares
-
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
por: Cohen, Fred, et al.
Publicado: (2022) -
Update of Neuromodulation in Chronic Migraine
por: Yuan, Hsiangkuo, et al.
Publicado: (2021) -
Novel Therapeutic Targets for Migraine
por: Nisar, Areeba, et al.
Publicado: (2023) -
Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations
por: Cohen, Fred, et al.
Publicado: (2022) -
Accompanying Symptoms Overlap during Attacks in Menière’s Disease and Vestibular Migraine
por: Lopez-Escamez, Jose Antonio, et al.
Publicado: (2014)